March 01, 2021
Article
Investigators used MRI scans of the heart to identify whether heart injury was caused by COVID-19 infection.
February 26, 2021
On Friday, a panel of advisors to the FDA voted to recommend Johnson & Johnson's COVID-19 vaccine, named Ad26.COV2.S, for emergency approval.
February 23, 2021
The approval of the first-line treatment was granted to Regeneron Pharmaceuticals.
February 18, 2021
Once-weekly semaglutide 2.4 mg resulted in sustained reductions in weight for those who are overweight or obese, the investigators reported.